Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ander Cohen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Future Cardiology|June 2, 2017
Interview with Alexander CohenAlexander Ander Cohen
Seminars in Thrombosis and Hemostasis|January 22, 2003
Thromboembolic disease in surgery for malignancy-rationale for prolonged thromboprophylaxisAmjad Khushal, Dan Quinlan, Raza Alikhan, et al.
Thrombosis and Haemostasis|November 17, 2020
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio StudyWalter Ageno, Maria Cristina Vedovati, Ander Cohen, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 25, 2018
Two Year Outcome After Chronic Iliac Vein Occlusion Recanalisation Using the Vici Venous Stent<sup>®</sup>Stephen Black, Adam Gwozdz, Narayan Karunanithy, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|November 13, 2020
Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stentsAdam M Gwozdz, Andrew J Doyle, Beverley J Hunt, et al.
Health Technology Assessment (Winchester, England)|October 23, 2015
A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT)Simon I Noble, Annmarie Nelson, David Fitzmaurice, et al.
Journal of Thrombosis and Thrombolysis|July 10, 2014
D-Dimer elevation and adverse outcomesRim Halaby, Christopher J Popma, Ander Cohen, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Future Cardiology|June 2, 2017
Interview with Alexander CohenAlexander Ander Cohen
Seminars in Thrombosis and Hemostasis|January 22, 2003
Thromboembolic disease in surgery for malignancy-rationale for prolonged thromboprophylaxisAmjad Khushal, Dan Quinlan, Raza Alikhan, et al.
Thrombosis and Haemostasis|November 17, 2020
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio StudyWalter Ageno, Maria Cristina Vedovati, Ander Cohen, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|August 25, 2018
Two Year Outcome After Chronic Iliac Vein Occlusion Recanalisation Using the Vici Venous Stent<sup>®</sup>Stephen Black, Adam Gwozdz, Narayan Karunanithy, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|November 13, 2020
Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stentsAdam M Gwozdz, Andrew J Doyle, Beverley J Hunt, et al.
Health Technology Assessment (Winchester, England)|October 23, 2015
A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT)Simon I Noble, Annmarie Nelson, David Fitzmaurice, et al.
Journal of Thrombosis and Thrombolysis|July 10, 2014
D-Dimer elevation and adverse outcomesRim Halaby, Christopher J Popma, Ander Cohen, et al.
Pageof 1